- Olokizumab
-
Olokizumab ? Monoclonal antibody Type Whole antibody Source Humanized Target IL6 Clinical data Pregnancy cat. ? Legal status ? Identifiers CAS number 1007223-17-7 ATC code None Chemical data Formula ? (what is this?) (verify) Olokizumab is an immunomodulator. It binds to interleukin 6.[1]
References
- ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information. http://www.who.int/medicines/publications/druginformation/INN_PL103.pdf.
Monoclonal antibodies for the immune system Immune system ("-l(i[m])-") Interleukin ("-k(i[n])-") Human ("-kinu-")Briakinumab • Canakinumab • Fezakinumab • Secukinumab • Sirukumab • Tralokinumab • UstekinumabHumanized ("-kizu-", "-kinzu-")Anrukinzumab • Enokizumab • Gevokizumab • Ixekizumab • Lebrikizumab • OlokizumabInflammatory lesions ("-les-") Mouse ("-leso-")This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.